e-learning
resources
ERJ
2022
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant protein C mutations and familial pulmonary fibrosis: stuck in a loop on the scenic route
Bibek Gooptu
Source:
Eur Respir J, 59 (1) 2102147; 10.1183/13993003.02147-2021
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bibek Gooptu. Surfactant protein C mutations and familial pulmonary fibrosis: stuck in a loop on the scenic route. Eur Respir J, 59 (1) 2102147; 10.1183/13993003.02147-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred
Source: Eur Respir J 2011; 38: 861-869
Year: 2011
A new mutation of surfactant protein C gene causing severe respiratory insufficiency and pulmonary fibrosis
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012
A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias
Source: Eur Respir J 2007; 29: 134-137
Year: 2007
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene
Source: Eur Respir J 2004; 24: 30-39
Year: 2004
Role of
ABCA3
in paediatric interstitial lung disease associated with surfactant protein C gene mutations
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population
Source: Eur Respir J 2001; 18: 482-490
Year: 2001
Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B
Source: Eur Respir J 2011; 38: 985-987
Year: 2011
Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient
Source: Eur Respir J 2002; 19: 374-376
Year: 2002
Epithelial pIgR: A new player in idiopathic pulmonary fibrosis?
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005
Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations
Source: Eur Respir J 2014; 43: 638-641
Year: 2013
LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
Old and novel surfactant protein C (SP-C) mutations in children
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Surfactant protein D as a potential serum marker of pulmonary emphysema
Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Year: 2011
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
Source: Eur Respir J 2011; 37: 59-69
Year: 2011
Protein truncating mutations in ATP13A3 promote pulmonary arterial hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept